Literature DB >> 8566840

Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide.

F Nevens1, W Van Steenbergen, S H Yap, J Fevery.   

Abstract

Octreotide has been proposed for the treatment of variceal bleeding. The effects on portal pressure, however, have been variable in published studies. As bleeding is more directly related to pressure in the varices, this study investigated the effect on variceal pressure of octreotide and terlipressin, a vasoactive drug with a well established effect. Variceal pressure was measured during four to eight minutes by a continuous non-invasive endoscopic registration method. Thirty patients in whom a stable variceal pressure recording had been obtained during at least one minute, were randomised to receive either 2 mg terlipressin, 50 micrograms octreotide or an identical volume of saline, as a single intravenous injection given over 60 seconds. For the final analysis three patients had to be excluded because of lack of a satisfactory recording. There were no significant clinical differences between the three groups of patients. Placebo administration did not induce significant changes, but a mean decrease in variceal pressure of -27% was noted with terlipressin, starting from two minutes onwards. Variceal pressure changes after injection of octreotide were variable and the mean change in pressure did not reach statistical significance. Seven of 10 patients showed a temporary increase in variceal pressure. In conclusion, terlipressin induces a significant and progressive decrease in variceal pressure but inconsistent variations of variceal pressure changes were seen after octreotide administration. This is probably related to its effect on central venous pressure. This study also shows that continuous variceal pressure recording with the non-invasive endoscopic registration technique detects in an accurate way the effect of vasoactive drugs on variceal pressure, because placebo injection did not produce significant changes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566840      PMCID: PMC1382991          DOI: 10.1136/gut.38.1.129

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding.

Authors:  J G Freeman; I Cobden; C O Record
Journal:  J Clin Gastroenterol       Date:  1989-02       Impact factor: 3.062

2.  Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage.

Authors:  J Rigau; J Bosch; J M Bordas; M Navasa; R Mastai; D Kravetz; J Bruix; F Feu; J Rodés
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

3.  Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy.

Authors:  J Bosch; J M Bordas; J Rigau; C Viola; R Mastai; D Kravetz; M Navasa; J Rodés
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

4.  The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis.

Authors:  F Nevens; D Sprengers; J Fevery
Journal:  J Hepatol       Date:  1994-01       Impact factor: 25.083

5.  Nonaggressive assessment of portal hypertension using endoscopic measurement of variceal pressure. Preliminary report.

Authors:  R Mosimann
Journal:  Am J Surg       Date:  1982-02       Impact factor: 2.565

6.  Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study.

Authors:  S Walker; A Stiehl; R Raedsch; B Kommerell
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

7.  Portal pressure, presence of gastroesophageal varices and variceal bleeding.

Authors:  G Garcia-Tsao; R J Groszmann; R L Fisher; H O Conn; C E Atterbury; M Glickman
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

8.  Effect of Valsalva's manoeuvre and hyoscinbutylbromide on the pressure gradient across the wall of oesophageal varices.

Authors:  S W Hosking; P Robinson; A G Johnson
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

9.  Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics.

Authors:  G Kleber; T Sauerbruch; G Fischer; G Paumgartner
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

10.  Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis.

Authors:  L S Eriksson; T Brundin; C Söderlund; J Wahren
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

View more
  8 in total

Review 1.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

2.  Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.

Authors:  Sanjeev Kumar Jha; Manish Mishra; Ashish Jha; Vishwa Mohan Dayal
Journal:  Indian J Gastroenterol       Date:  2018-08-21

3.  Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension.

Authors:  E A El Atti; F Nevens; K Bogaerts; G Verbeke; J Fevery
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 4.  When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS?

Authors:  Martin Rössle
Journal:  Langenbecks Arch Surg       Date:  2003-05-01       Impact factor: 3.445

Review 5.  Variceal bleeding : pharmacological treatment and prophylactic strategies.

Authors:  Cándid Villanueva; Joaquim Balanzó
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

7.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

Review 8.  Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.

Authors:  Mladena Glavaš; Agata Gitlin-Domagalska; Dawid Dębowski; Natalia Ptaszyńska; Anna Łęgowska; Krzysztof Rolka
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.